Raman Singh
@tobeneurologist
PGY-4 @OU_Neurology. Incoming Vascular Neurology Fellow @HenryFordNeuro. Avid EEGer. Aspiring endovascular Neurologist. Indo-Lebanese🗣️🇺🇲🇱🇧🇮🇳🇫🇷🇷🇺🇪🇸
ID: 1316122928820498433
https://www.linkedin.com/in/raman-singh-m-b-b-s-3366891a2 13-10-2020 21:05:46
319 Tweet
477 Followers
665 Following
🔥HOT OFF THE PRESS SVIN #SVINAM23 Size does NOT matter! 🫨 Chris Favilla University of Pennsylvania Neurology shows infarct DENSITY outperforms infarct SIZE in predicting outcome after recanalization success with LVO! Fawaz Al-Mufti, MD, FSVIN AHAMeetings Stroke AHA/ASA
Congrats Fawaz Al-Mufti, MD, FSVIN & Alexandra Czap for an outstanding job as #SVIN23 meeting chairs. Thank you for your distinguished service Ameer E. Hassan & Best Wishes to Thanh Nguyen 🇺🇦 as SVIN's new President. I am proud of SVIN accomplishments and optimistic about it's future !!
Apply and get involved Deadline tomorrow!!! Mission Thrombectomy Stroke: Vascular and Interventional Neurology SVIN YoungNIR WINN 🇺🇦 SNIS Info Stroke AHA/ASA World Stroke Org Neuroangio
Thank you Shadi Yaghi for moderating SVIN Games! Learned a lot! @bharatpillai_ Jim Siegler, Dad, Husband, MD SVIN #SVINAM #SVIN23
Thank you Imperative Care Vascular ! Zoom has helped us save penumbra in cute little kids at our institution with large vessel occlusions, great results post-op!
#SVINAM was phenomenal. Learned a lot, got to present my work, met amazing accomplised people in the field, had a lot of fun as well! Thank you Fawaz Al-Mufti, MD, FSVIN and team for organizing this! Looking forward to meeting you all next year in San Diego! SVIN Stroke: Vascular and Interventional Neurology
Thanks to #SVIN for inviting us to present the Ally Pilot Trial. First study to investigate IA Tenecteplase post MT in TICI 2b & 2c patients. Rx given as 1.5 mg bolus - max 4.5 mg. Appreciate Mouhammad Jumaa AshuJadhav Alicia Castonguay, PhD FSVIN FAHA Diogo Haussen Sunil Sheth, MD Osama Zaidat MD
A timely review in light of ARTESIA! Subclinical AF is a dynamic process with increasing burden over time. Apixaban lowered the risk of recurrent stroke but with increased bleeding, thus individualized decision making is important. Luciano Sposato 🇦🇷🇨🇦 Edip Gurol ahajournals.org/doi/10.1161/ST…